Sean Ellis insider trades: Entera Bio (ENTX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sean reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | ENTX | ↑ Buy | 10,000 | $1.23 | $12K | Direct | Mar 9, 2026 (4d) |
| Feb 9, 2026 | ENTX | ↑ Buy | 18,000 | $1.24 | $22K | Direct | Feb 11, 2026 (2d) |
| Aug 21, 2023 | ENTX | ↑ Buy | 40,000 | $0.60 | $24K | Direct | Aug 22, 2023 (1d) |
| Nov 11, 2022 | ENTX | ↑ Buy | 30,000 | $0.53 | $16K | Direct | Nov 14, 2022 (3d) |
| Jul 21, 2022 | ENTX | ↑ Buy | 14,900 | $1.64 | $24K | Direct | Jul 25, 2022 (4d) |
| Jan 18, 2022 | ENTX | ↑ Buy | 10,000 | $2.81 | $28K | Direct | Jan 19, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ENTX insiders
Open-market trades in the last 12 months
About Sean Ellis's insider trades
Sean Ellis is a director at Entera Bio (ENTX). Since Jan 18, 2022, Sean has reported 6 open-market purchases worth $127K and no sales on SEC Form 4. In the last 12 months: 2 buys ($35K).
Their filings also include grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ENTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.